Aimgenixo Private Limited is a specialized biopharma startup introducing OLEO PATCH™: An anhydrous thixotropic bio-film matrix designed for advanced specialty oral care /dentistry and oncology palliative supportive care. This innovation addresses massive gaps in dental therapeutics: 1) The 2 minutes rapid washout and low bioavailability of standard oral toothpastes, gels and ointments. 2) A critical gap in oncology supportive medicine: Chemotherapy-Induced Oral Mucositis (CIOM) and Xerostomia (severe dry mouth). Current therapeutic gels rely on water & quickly wash away by saliva or ethanol bases that cause excruciating chemical stings on denuded oral tissues. This lipid matrix formulation acts as a sustained-release drug delivery system that adheres effectively to oral tissues, providing localized, continuous therapeutic action without being prematurely degraded by saliva and soothing on ulcers (it forms a 100% alcohol-free, non-stinging protective mechanical shield over raw ulcers). To protect this proprietary technology, an Indian provisional patent has already been filed, establishing a strong intellectual property foundation. Operationally, the company is gaining significant institutional validation. Currently we are formally associated as an incubatee at the prestigious BSC BioNEST-Regional Centre of Biotechnology (Faridabad). Our business model is highly scalable, targeting both the massive consumer oral care sector and clinical dental pharmacology. By anchoring our corporate and research roots in Noida, Uttar Pradesh, Aimgenixo aims to generate high-value biotechnology roles, foster regional academic-industry collaborations, and establish UP as a hub for advanced biomedical innovations. Additional Economic Impact: OLEO PATCH™ operates as a high-margin domestic import substitute for specialized oncology oral care gels (currently imported at ₹5,000–₹11,000 per cycle), presenting a projected national Forex saving of ₹120+ Crore ($14.5M) annually.
Show MoreYear of Establishment2026